Open-label, randomized study of individualized, pharmacokinetically (PK)-guided dosing of paclitaxel combined with carboplatin or cisplatin in patients with advanced non-small-cell lung cancer (NSCLC).
Saved in:
| Title: | Open-label, randomized study of individualized, pharmacokinetically (PK)-guided dosing of paclitaxel combined with carboplatin or cisplatin in patients with advanced non-small-cell lung cancer (NSCLC). |
|---|---|
| Authors: | Joerger M; Department of Medical Oncology, Cantonal Hospital, St Gallen, Switzerland markus.joerger@kssg.ch., von Pawel J; Pneumology Clinic, Asklepios Fachkliniken, Gauting., Kraff S; Institute of Pharmacy, Clinical Pharmacy, University of Bonn, Bonn., Fischer JR; Department of Medical Oncology, Klinik Löwenstein, Löwenstein., Eberhardt W; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen., Gauler TC; Department of Medical Oncology (Cancer Research), West German Cancer Center, University Hospital Essen of University Duisburg-Essen, Essen., Mueller L; Oncological Practice, Praxis Leer, Leer., Reinmuth N; Lung Clinic Grosshansdorf, Airway Research Center North (ARCN), Member of the German Center for Lung Research (DZL), Grosshansdorf., Reck M; Lung Clinic Grosshansdorf, Airway Research Center North (ARCN), Member of the German Center for Lung Research (DZL), Grosshansdorf., Kimmich M; Pulmonology and Oncology, Klinik Schillerhöhe, Gerlingen., Mayer F; Department of Oncology and Hematology, University Hospital, Medical Center II, Tübingen., Kopp HG; Department of Oncology and Hematology, Eberhard Karls University Medical Center, Tübingen., Behringer DM; Medical Oncology, Augusta-Kranken-Anstalt, Bochum., Ko YD; Medical Oncology, Johanniter-Krankenhaus Bonn, Bonn., Hilger RA; Cancer Research, University Hospital Essen, Essen, Germany., Roessler M; CESAR Central Office (CCO), Vienna CESAR Central European Society for Anticancer Drug Research-EWIV, Vienna, Austria., Kloft C; Department of Clinical Pharmacy and Biochemistry, Institute of Pharmacy, Free University Berlin, Berlin, Germany., Henrich A; Department of Clinical Pharmacy and Biochemistry, Institute of Pharmacy, Free University Berlin, Berlin, Germany., Moritz B; CESAR Central Office (CCO), Vienna CESAR Central European Society for Anticancer Drug Research-EWIV, Vienna, Austria., Miller MC; Saladax Biomedical, Inc., Bethlehem, USA., Salamone SJ; Saladax Biomedical, Inc., Bethlehem, USA., Jaehde U; Institute of Pharmacy, Clinical Pharmacy, University of Bonn, Bonn. |
| Source: | Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2016 Oct; Vol. 27 (10), pp. 1895-902. Date of Electronic Publication: 2016 Aug 08. |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 27502710 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Open-label, randomized study of individualized, pharmacokinetically (PK)-guided dosing of paclitaxel combined with carboplatin or cisplatin in patients with advanced non-small-cell lung cancer (NSCLC). – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Joerger+M%22">Joerger M</searchLink>; Department of Medical Oncology, Cantonal Hospital, St Gallen, Switzerland markus.joerger@kssg.ch.<br /><searchLink fieldCode="AU" term="%22von+Pawel+J%22">von Pawel J</searchLink>; Pneumology Clinic, Asklepios Fachkliniken, Gauting.<br /><searchLink fieldCode="AU" term="%22Kraff+S%22">Kraff S</searchLink>; Institute of Pharmacy, Clinical Pharmacy, University of Bonn, Bonn.<br /><searchLink fieldCode="AU" term="%22Fischer+JR%22">Fischer JR</searchLink>; Department of Medical Oncology, Klinik Löwenstein, Löwenstein.<br /><searchLink fieldCode="AU" term="%22Eberhardt+W%22">Eberhardt W</searchLink>; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen.<br /><searchLink fieldCode="AU" term="%22Gauler+TC%22">Gauler TC</searchLink>; Department of Medical Oncology (Cancer Research), West German Cancer Center, University Hospital Essen of University Duisburg-Essen, Essen.<br /><searchLink fieldCode="AU" term="%22Mueller+L%22">Mueller L</searchLink>; Oncological Practice, Praxis Leer, Leer.<br /><searchLink fieldCode="AU" term="%22Reinmuth+N%22">Reinmuth N</searchLink>; Lung Clinic Grosshansdorf, Airway Research Center North (ARCN), Member of the German Center for Lung Research (DZL), Grosshansdorf.<br /><searchLink fieldCode="AU" term="%22Reck+M%22">Reck M</searchLink>; Lung Clinic Grosshansdorf, Airway Research Center North (ARCN), Member of the German Center for Lung Research (DZL), Grosshansdorf.<br /><searchLink fieldCode="AU" term="%22Kimmich+M%22">Kimmich M</searchLink>; Pulmonology and Oncology, Klinik Schillerhöhe, Gerlingen.<br /><searchLink fieldCode="AU" term="%22Mayer+F%22">Mayer F</searchLink>; Department of Oncology and Hematology, University Hospital, Medical Center II, Tübingen.<br /><searchLink fieldCode="AU" term="%22Kopp+HG%22">Kopp HG</searchLink>; Department of Oncology and Hematology, Eberhard Karls University Medical Center, Tübingen.<br /><searchLink fieldCode="AU" term="%22Behringer+DM%22">Behringer DM</searchLink>; Medical Oncology, Augusta-Kranken-Anstalt, Bochum.<br /><searchLink fieldCode="AU" term="%22Ko+YD%22">Ko YD</searchLink>; Medical Oncology, Johanniter-Krankenhaus Bonn, Bonn.<br /><searchLink fieldCode="AU" term="%22Hilger+RA%22">Hilger RA</searchLink>; Cancer Research, University Hospital Essen, Essen, Germany.<br /><searchLink fieldCode="AU" term="%22Roessler+M%22">Roessler M</searchLink>; CESAR Central Office (CCO), Vienna CESAR Central European Society for Anticancer Drug Research-EWIV, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Kloft+C%22">Kloft C</searchLink>; Department of Clinical Pharmacy and Biochemistry, Institute of Pharmacy, Free University Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Henrich+A%22">Henrich A</searchLink>; Department of Clinical Pharmacy and Biochemistry, Institute of Pharmacy, Free University Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Moritz+B%22">Moritz B</searchLink>; CESAR Central Office (CCO), Vienna CESAR Central European Society for Anticancer Drug Research-EWIV, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Miller+MC%22">Miller MC</searchLink>; Saladax Biomedical, Inc., Bethlehem, USA.<br /><searchLink fieldCode="AU" term="%22Salamone+SJ%22">Salamone SJ</searchLink>; Saladax Biomedical, Inc., Bethlehem, USA.<br /><searchLink fieldCode="AU" term="%22Jaehde+U%22">Jaehde U</searchLink>; Institute of Pharmacy, Clinical Pharmacy, University of Bonn, Bonn. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229007735%22">Annals of oncology : official journal of the European Society for Medical Oncology</searchLink> [Ann Oncol] 2016 Oct; Vol. 27 (10), pp. 1895-902. <i>Date of Electronic Publication: </i>2016 Aug 08. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9007735 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1569-8041 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209237534%22">09237534 </searchLink><i>NLM ISO Abbreviation: </i>Ann Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=27502710 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/annonc/mdw290 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1895 Titles: – TitleFull: Open-label, randomized study of individualized, pharmacokinetically (PK)-guided dosing of paclitaxel combined with carboplatin or cisplatin in patients with advanced non-small-cell lung cancer (NSCLC). Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Joerger M – PersonEntity: Name: NameFull: von Pawel J – PersonEntity: Name: NameFull: Kraff S – PersonEntity: Name: NameFull: Fischer JR – PersonEntity: Name: NameFull: Eberhardt W – PersonEntity: Name: NameFull: Gauler TC – PersonEntity: Name: NameFull: Mueller L – PersonEntity: Name: NameFull: Reinmuth N – PersonEntity: Name: NameFull: Reck M – PersonEntity: Name: NameFull: Kimmich M – PersonEntity: Name: NameFull: Mayer F – PersonEntity: Name: NameFull: Kopp HG – PersonEntity: Name: NameFull: Behringer DM – PersonEntity: Name: NameFull: Ko YD – PersonEntity: Name: NameFull: Hilger RA – PersonEntity: Name: NameFull: Roessler M – PersonEntity: Name: NameFull: Kloft C – PersonEntity: Name: NameFull: Henrich A – PersonEntity: Name: NameFull: Moritz B – PersonEntity: Name: NameFull: Miller MC – PersonEntity: Name: NameFull: Salamone SJ – PersonEntity: Name: NameFull: Jaehde U IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 10 Text: 2016 Oct Type: published Y: 2016 Identifiers: – Type: issn-electronic Value: 1569-8041 Numbering: – Type: volume Value: 27 – Type: issue Value: 10 Titles: – TitleFull: Annals of oncology : official journal of the European Society for Medical Oncology Type: main |
| ResultId | 1 |